Marju Tilly-Kiesi

671 total citations
23 papers, 568 citations indexed

About

Marju Tilly-Kiesi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marju Tilly-Kiesi has authored 23 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marju Tilly-Kiesi's work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipoproteins and Cardiovascular Health (12 papers) and Cancer, Lipids, and Metabolism (5 papers). Marju Tilly-Kiesi is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipoproteins and Cardiovascular Health (12 papers) and Cancer, Lipids, and Metabolism (5 papers). Marju Tilly-Kiesi collaborates with scholars based in Finland, United Kingdom and United States. Marju Tilly-Kiesi's co-authors include Marja‐Riitta Taskinen, Sanni Lahdenperä, Matti J. Tikkanen, Juhani Kahri, H. Vuorinen-Markkola, Timo Kuusi, Christian Ehnholm, Alice H. Lichtenstein, T Kuusi and Sonja Ehnholm and has published in prestigious journals such as Diabetes Care, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Marju Tilly-Kiesi

23 papers receiving 548 citations

Peers

Countries citing papers authored by Marju Tilly-Kiesi

Since Specialization

Citations

This map shows the geographic impact of Marju Tilly-Kiesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marju Tilly-Kiesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marju Tilly-Kiesi more than expected).

Fields of papers citing papers by Marju Tilly-Kiesi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marju Tilly-Kiesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marju Tilly-Kiesi. The network helps show where Marju Tilly-Kiesi may publish in the future.

Co-authorship network of co-authors of Marju Tilly-Kiesi

This figure shows the co-authorship network connecting the top 25 collaborators of Marju Tilly-Kiesi. A scholar is included among the top collaborators of Marju Tilly-Kiesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marju Tilly-Kiesi. Marju Tilly-Kiesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lipoprotein metabolism in subjects with hepatic lipase deficiency 2004 ·Metabolism ·Marju Tilly-Kiesi, Ernst J. Schaefer, (unknown), Francine K. Welty, Gregory G. Dolnikowski, Marja‐Riitta Taskinen, Alice H. Lichtenstein	15
2	Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107→0) 1998 ·Atherosclerosis ·Marju Tilly-Kiesi, Alice H. Lichtenstein, (unknown), Marja‐Riitta Taskinen	3
3	Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states 1998 ·Atherosclerosis ·Richard W. James, (unknown), Laura Calabresi, Roberto Miccoli, Arnold von Eckardstein, Marju Tilly-Kiesi, Marja‐Riitta Taskinen, Gerd Assmann, Guido Franceschini	54
4	Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients 1998 ·Diabetologia ·G. Romanò, Marju Tilly-Kiesi, L. Patti, Marja‐Riitta Taskinen, D. Pacioni, Maurizio Cassader, Gabriele Riccardi, Angela A. Rivellese	18
5	In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107→0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency 1997 ·Atherosclerosis ·Marju Tilly-Kiesi, C.J. Packard, Juhani Kahri, Christian Ehnholm, J. Shepherd, Marja‐Riitta Taskinen	14
6	Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·Marju Tilly-Kiesi, Alice H. Lichtenstein, Jorge Joven, Elisabet Vilella, Marian C. Cheung, (unknown), José M. Ordovás, Gregory G. Dolnikowski, Ernst J. Schaefer	27
7	Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen–progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women 1997 ·Atherosclerosis ·Marju Tilly-Kiesi, Juhani Kahri, T Pýörälä, Jukka Puolakka, H. Luotola, (unknown), Sanni Lahdenperä, Marja‐Riitta Taskinen	20
8	Subjects With ApoA-I(Lys ₁₀₇ →0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·Marju Tilly-Kiesi, Alice H. Lichtenstein, José M. Ordovás, Gregory G. Dolnikowski, Raija Malmström, Marja‐Riitta Taskinen, Ernst J. Schaefer	28
9	Different effects of continuous oestrogen–progestin and transdermal oestrogen with cyclic progestin regimens on low‐density lipoprotein subclasses 1996 ·European Journal of Clinical Investigation ·Marju Tilly-Kiesi, Marjatta Lappi, Jukka Puolakka, H. Luotola, T Pýörälä, Marja‐Riitta Taskinen	15
10	Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group. 1996 ·Journal of Lipid Research ·Marju Tilly-Kiesi, (unknown), Leif Groop, Marja‐Riitta Taskinen	23
11	Hyperlipidemia enhances chronic rejection in experimental rat model. 1995 ·PubMed ·Marju Tilly-Kiesi, Anne Räisänen‐Sokolowski, Jarkko Ustinov, Marjukka Myllärniemi, (unknown), P Häyry	3
12	Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat. 1994 ·Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Anne Räisänen‐Sokolowski, Marju Tilly-Kiesi, Jarkko Ustinov, Ari Mennander, Timo Paavonen, Minna Tikkanen, P Häyry	35
13	LDL subclasses in IDDM patients: relation to diabetic nephropathy 1994 ·Diabetologia ·(unknown), Per‐Henrik Groop, Marju Tilly-Kiesi, T Kuusi, (unknown), G. C. Viberti, Marja‐Riitta Taskinen	3
14	LDL subclasses in IDDM patients: relation to diabetic nephropathy 1994 ·Diabetologia ·(unknown), Per‐Henrik Groop, Marju Tilly-Kiesi, T Kuusi, (unknown), Gian Carlo Viberti, Marja‐Riitta Taskinen	29
15	Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity 1993 ·Atherosclerosis ·Juhani Kahri, H. Vuorinen-Markkola, Marju Tilly-Kiesi, Sanni Lahdenperä, Marja‐Riitta Taskinen	26
16	Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia. 1992 ·PubMed ·Marju Tilly-Kiesi, (unknown)	8
17	Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. 1992 ·Journal of Lipid Research ·Marju Tilly-Kiesi, Mikko Syvänne, T Kuusi, Sanni Lahdenperä, Marja‐Riitta Taskinen	29
18	Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil 1991 ·Journal of Internal Medicine ·Marju Tilly-Kiesi, Matti J. Tikkanen	38
19	The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia 1991 ·Metabolism ·Marju Tilly-Kiesi	22
20	Differential low density lipoprotein hydrated density distribution in female and male patients with familial hypercholesterolemia 1991 ·Clinica Chimica Acta ·Marju Tilly-Kiesi, Matti J. Tikkanen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact